Convatec Group PLC engages in the development, manufacturing, and sale of medical products, services and technologies for the management of chronic conditions in Europe, North America, and internationally. The company offers advanced wound care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, bladder cancer, inflammatory bowel disease, and trauma. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, neurological disease, prostate enlargement or other causes. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for use in continuous infusion treatments for conditions such as Parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. Convatec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.

Currency in USD	2025
Operating Income	386.00 Million
Income Before Tax	230.00 Million
Income Tax Expense	55.00 Million
Net Income	175.00 Million
Eps	0.09
Epsdiluted	0.09
Weighted Average Shs Out	2.02 Billion
Weighted Average Shs Out Dil	2.03 Billion
Depreciation And Amortization	224.00 Million
Interest Expense	62.00 Million
Ebit	292.00 Million
Period	FY
Ebitda	610.00 Million
Net Cash Provided By Operating Activities	N/A

Convatec Group PLC Annual Reports (10-K)